Ignite Creation Date:
2024-05-06 @ 5:52 PM
Last Modification Date:
2024-10-26 @ 2:37 PM
Study NCT ID:
NCT05458635
Status:
COMPLETED
Last Update Posted:
2022-07-14
First Post:
2022-07-04
Brief Title:
Predictors of Pulmonary Hypertension in Patients With Hypersensitivity Pneumonitis
Sponsor:
Cairo University
Organization:
Cairo University
Study Overview
Official Title:
Predictors of Pulmonary Hypertension in Patients With Hypersensitivity Pneumonitis
Status:
COMPLETED
Status Verified Date:
2022-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Hypersensitivity pneumonitis HP is a complex immune mediated disorders caused by repeated inhalation of and sensitization to wide range of antigens including organic particles and chemical compounds leading to exaggerated immuneresponse Hypersenstivity pneumonitis is a common form of diffuse parenchymal lung diseases in Egypt Pulmonary hypertension has been found as a complication of a number of diseases affecting the lung interstitium including hypersensitivity pneumonitis with subsequent affection of the life expectancy Rationale of the study to find predictors for the development of pulmonary hypertension in patients with hypersensitivity pneumonitis
Detailed Description:
Cross sectional study included 60 patients with established diagnosis of HP work up includes history of exposure clinical examination HRCT chest ABGs6MWD desaturation degree spirometry echocardiography and right heart catheter in patients with high echo probability of PH
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None